Investigating the Effect of Topical Imiquimod on Sebaceous Hyperplasia

Recruiting

ImiquimodInvestigating the Effect of Topical Imiquimod on Sebaceous Hyperplasia

Sponsor:

University of Michigan

Code:

NCT06840470

Conditions

Sebaceous Hyperplasia

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Imiquimod 5% Topical Cream

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-01. This information was provided to ClinicalTrials.gov by University of Michigan on 2025-04-01.